| ²é¿´: 785 | »Ø¸´: 1 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
christianľ³æ (ÕýʽдÊÖ)
|
[½»Á÷]
GMP³£Óôʻã
|
||
|
ÒѾÊÕË÷£¬ÎÞÖØ¸´ GMPÓ¢Óï PIC/SµÄÈ«³ÆÎª£ºPharmaceutical Inspection Convention/Pharmaceutical Inspection Cooperation Scheme, PIC/S(ÖÆÒ©¼ì²é²Ý°¸), Ò©Æ·¼ì²éлá(PIC/S) ,Ò²ÓÐÈ˳ÆPIC/SΪҽҩÉó²é»áÒé/ºÏ×÷¼Æ»®£¨PIC/S£© PICµÄȨÍþ·Ò룺ҩƷÉú²ú¼ì²éÏ໥³ÐÈϹ«Ô¼ API(Active Pharmaceutical Ingrediet) ÔÁÏÒ© Óֳƣº»îÐÔÒ©Îï×é·Ö AirLock ÆøÕ¢ Authorized Person ÊÚȨÈË Batch/Lot Åú´Î Batch Number/Lot-Number ÅúºÅ£»Batch Numbering System Åú´Î±àÂëϵͳ£» Batch Records Åú¼Ç¼£»Bulk Product ´ý°ü×°Æ·£»Calibration УÕý£»Clean area½à¾»Çø£»Consignmecnt£¨Delivery£©ÍÐÏúÒ©Æ·¡£ FDA£¨FOOD AND DRUG ADMINISTRATION£©£º£¨ÃÀ¹ú£©Ê³Æ·Ò©Æ·¹ÜÀí¾Ö IND£¨INVESTIGATIONAL NEW DRUG£©£ºÁÙ´²Ñо¿ÉêÇ루ָÉ걨½×¶Î,Ïà¶ÔÓÚNDA¶ø ÑÔ£©£»Ñо¿ÖеÄÐÂÒ©£¨Ö¸ÐÂÒ©¿ª·¢½×¶Î£¬Ïà¶ÔÓÚÐÂÒ©¶øÑÔ£¬¼´ÁÙ´²Ç°Ñо¿½áÊø£© NDA£¨NEW DRUG APPLICATION£©£ºÐÂÒ©ÉêÇë ANDA£¨ABBREVIATED NEW DRUG APPLICATION£©£º¼ò»¯ÐÂÒ©ÉêÇë TREATMENT IND£ºÑо¿ÖеÄÐÂÒ©ÓÃÓÚÖÎÁÆ ABBREVIATED£¨NEW£©DRUG£º¼ò»¯ÉêÇëµÄÐÂÒ© DMF£¨DRUG MASTER FILE£©£ºÒ©ÎïÖ÷Îļþ£¨³ÖÓÐÕßΪ½÷É÷Æð¼û¶ø×¼±¸µÄ±£ÃÜ×ÊÁÏ£¬¿ÉÒÔ °üÀ¨Ò»¸ö»ò¶à¸öÈËÓÃÒ©ÎïÔÚÖÆ±¸¡¢¼Ó¹¤¡¢°ü×°ºÍÖü´æ¹ý³ÌÖÐËùÉæ¼°µÄÉ豸¡¢Éú²ú¹ý³Ì»òÎï Æ·¡£Ö»ÓÐÔÚDMF³ÖÓÐÕß»òÊÚȨ´ú±íÒÔÊÚȨÊéµÄÐÎʽÊÚȨ¸øFDA£¬FDAÔÚÉó²éIND¡¢ NDA¡¢ANDAʱ²ÅÄܲο¼ÆäÄÚÈÝ£© HOLDER£ºDMF³ÖÓÐÕß CFR£¨CODE OF FEDERAL REGULATION£©£º£¨ÃÀ¹ú£©Áª°î·¨¹æ PANEL£º×¨¼ÒС×é BATCH PRODUCTION£ºÅúÁ¿Éú²ú£»·ÖÅúÉú²ú BATCH PRODUCTION RECORDS£ºÉú²úÅúºÅ¼Ç¼ POST-OR PRE- MARKET SURVEILLANCE£ºÏúÊÛǰ»òÏúÊÛºó¼à¶½ INFORMED CONSENT£ºÖªÇéͬÒ⣨»¼Õß¶ÔÖÎÁÆ»òÊÜÊÔÕß¶ÔÒ½ÁÆÊÔÑéÁ˽âºó±íʾͬÒâ½ÓÊÜÖÎÁÆ»òÊÔÑ飩 PRESCRIPTION DRUG£º´¦·½Ò© OTC DRUG£¨OVER¡ªTHE¡ªCOUNTER DRUG£©£º·Ç´¦·½Ò© GMPÎļþ³£¼ûËõд ABPI Association of the British Pharmaceutical Industry ADR Adverse Drug Reaction AE Adverse Event AIM Active Ingredient Manufacturer ANDA Abbreviated New Drug Application ANOVA Analysis of Variance ASM: Active Substance Manufacturer ATC Anatomical Therapeutic Chemical ATX Animal Test Exemption Certificate BAN British Approved Name BIRA British Institute of Regulatory Affairs BNF British National Formulary BP British Pharmacopoeia C of A Certificate of Analysis C of S Certificate of Suitability CENTRE FOR DRUG EVALUATION (CDE) Centre for Pharmaceutical Administration (CPA) CMS Concerned Member State CMSÿ¸ö³ÉÔ±¹ú COS Certificate of Suitability CPMP Committee for Proprietary Medicinal Products CRA Clinical Research Associate CRF Case Report Form CRO Contract Research Organisation CTA Clinical Trial Application CTC Clinical Trial Certificate CTD Common Technical Document CTX Clinical Trials Exemption DDD Defined Daily Dose DGC Daily Global Comparison DIA Drug Information Association DMF Drug Master File Drug Registration Branch (DR, Product Evaluation & Registration Division, CPA EDQM (European Directorate for the Quality of Medicines) Å·ÖÞÁªÃËÒ©Æ·ÖÊÁ¿Ö¸µ¼Î¯Ô±»á EEA Å·ÖÞ¾¼ÃµØÇø EGMA European Generics Medicine Association ELA Established Licence Application EMEA European Medicines Evaluation Agency EMEA £¨European Agency for the Evaluation of Medicinal Products£© Å·ÖÞÁªÃËÒ©Æ·ÆÀ¼Û»ú¹¹ EP European Pharmacopoeia EPAR European Public Assessment Reports ESRA European Society of Regulatory Affairs European Pharmacopoeia Commission Å·ÖÞÒ©µäίԱ»á FDA FDA Food and Drug Administration final evaluation report (FER) free sale certificates (FSCs) GCP Good Clinical Practice GCPÒ©Æ·ÁÙ´²Ñо¿¹ÜÀí¹æ·¶ GLP Good Laboratory Practice GLP Ò©Æ·ÁÙ´²Ç°°²È«ÐÔÑо¿ÖÊÁ¿¹ÜÀí¹æ·¶ GMP Good Manufacturing Practice GMP Ò©Æ·Éú²úÖÊÁ¿¹ÜÀí¹æ·¶ GSPÒ©Æ·ÏúÊÛ¹ÜÀí¹æ·¶ Health Sciences Authority (HSA) HSA¡¯s Medicines Advisory Committee (MAC) IB Investigators Brochure ICH International Conference for Harmonisation IDMC Independent Data-Monitoring Committee IEC Independent Ethics Committee IND Investigational New Drug INN International Non-proprietary Name International Conference on Harmonisation (ICH) IPC In Process Control IRB Institutional Review Board LICENCE HOLDER MA Marketing Authorisation MAA Marketing Authorisation Application MAAÉÏÊÐÉêÇë MAH Marketing Authorisation Holder MAH ÏúÊÛÐí¿É³ÖÓÐÕß MCA Medicines Control Agency MHW Ministry of Health and Welfare (Japan) MR Mutual Recognition MRA ÃÀ¹úÓëÅ·Ã˵Ļ¥ÈÏÐÒé MRAs (Mutual Recognition Agreements) »¥ÏàÕJ×CͬÒâ MRFG Mutual Recognition Facilitation Group MRP Mutual Recognition Procedure NAS New Active Substance NCE New Chemical Entity NDA New Drug Application new chemical entities (NCEs) new drug applications (NDAs) NSAID Non Steroidal Anti Inflammatory Drug NTA Notice To Applicants OOS Out of Specification OTC Over The Counter PAGB Proprietary Association of Great Britain Ph Eur European Pharmacopoeia PIL Patient Information Leaflet PL Product Licence POM Prescription Only Medicine PRODUCT OWNER PSU Periodic Safety Updates QA Quality Assurance QC Quality Control RAJ Regulatory Affairs Journal RMS Reference Member State RMSÏ໥ÈÏ¿ÉÁíÒ»³ÉÔ±¹ú RSD Relative Standard Deviation Rx Prescription Only SAE Serious Adverse Event SMF Site Master File SOP Standard Operating Procedure SOP £¨STANDARD OPERATION PROCEDURE£© ±ê×¼ÔË×÷³ÌÐò SPC/SmPC Summary of Product Characteristics summary of product characteristics(SPC) Therapeutic Goods Administration (TGA) USP US Pharmacopoeia VMF Veterinary Master File VPC Veterinary Products Committee A£®A£®A Addition and Amendments Ôö²¹ºÍÐÞ¶© AC Air Conditioner ¿Õµ÷Æ÷ ADR Adverse Drug Reaction Ò©Îï²»Á¼·´Ó¦ AFDO Association of Food and Drug Officials ʳƷÓëÒ©Æ·¹ÙԱлᣨÃÀ¹ú£© ACC Accept ½ÓÊÜ AQL Acceptable Quality Level ºÏ¸ñÖÊÁ¿±ê×¼ ADNA Abbreviated New Drug Application ¼ò»¯µÄÐÂÒ©ÉêÇë BOM Bill of Material ÎïÁÏÇåµ¥ BPC Bulk pharmaceutical Chemiclls ÔÁÏÒ© CBER Center for Biologics Evaluation Research ÉúÎïÖÆÆ·ÆÀ¼ÛÓëÑо¿ÖÐÐÄ CFU Colony Forming Unet ¾úÂäÐγɵ¥Î» DMF Drug Master File Ò©Æ·¹ÜÀíµµ°¸ CDER Cemter for Drug Evaluation amd Research Ò©ÎïÆÀ¼ÛÓëÑо¿ÖÐÐÄ CI Corporate Identity (Image) Æóҵʶ±ð£¨ÐÎÏó£© CIP Cleaning in Place ÔÚÏßÇåÏ´ CSI Consumer Safety Insepctor Ïû·ÑÕß°²È«µ÷²éÔ± CLP Cleaning Line Procedure ÔÚÏßÇåÏ´³ÌÐò DAL Defect Action Level ȱÏÝ×÷ÓÃˮƽ DEA Drug Enforcement Adminestration ¹ÜÖÆÒ©Æ·¹ÜÀí DS Documentation Systim Îļþϵͳ FDA Food and Drug Administration ʳƷÓëÒ©Æ·¹ÜÀí¾Ö£¨ÃÀ¹ú£© GATT General Agreemernt on Tariffs and Trade ¹ØÃ³×Üлá GMP Good Manufacturing Practice Gvp Ò©Æ·ÉúÖÊÁ¿¹ÜÀí¹æ·¶ GCP Good Clinical Practice Ò©Æ·ÁÙ´²ÊµÑé¹ÜÀí¹æ·¶ GLP Good Laboratory Practice ʵÑéÊÒ¹ÜÀí¹æ·¶ GSP Good Supply Practice Ò©Æ·ÉÌÒµÖÊÁ¿¹æ·¶ GRP Gook RaTAIL Practice Ò©Æ·ÁãÒµÖÊÁ¿¹ÜÀí¹æ·¶ GAP Good Agriculture Practice Ò©²ÄÉú²ú¹ÜÀí¹æ·¶ GVP Gook Validation Prctice ÑéÖ¤¹ÜÀí¹æ·¶ GUP Gook Use Practice Ò©Æ·ÖØÓù淶 HVAC Heating Ventilation Air Conditioning ¿Õµ÷¾»»¯ÏµÍ³ ISO Intematonal Organization for Standardization ³µ¼Ê±ê×¼»¯×éÖ¯ MOU Memorandum of Understanding Á½ⱸÍü¼ PF Porduction File Éú²ú¼Ç¼Óñí¸ñ OTC Over the Counter (Drug) ·Ç´¦·½Ò©Æ· PLA Product License Application ²úÆ·Ðí¿ÉÉêÇë QA Quality Assurance ÖÊÁ¿±£Ö¤ QC Quality Control ÖÊÁ¿¿ØÖÆ QMP Quality Management Procedure ÖÊÁ¿¹ÜÀí³ÌÐò SDA State Drug Administration ¹ú¼ÒÒ©Æ·¼à¶½¹ÜÀí¾Ö SMP Standard Managmert Procedure ±ê×¼¹ÜÀí³ÌÐò SOP Standard Operating Procedure ±ê×¼²Ù×÷³ÌÐò TQC Tatal Quality Control È«ÃæÖÊÁ¿¹ÜÀí USA Uneted States Pharmacopeia ÃÀ¹úÒ©µä |
» ²ÂÄãϲ»¶
¹¤¿Æ²ÄÁÏ085601 279Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
¡¾¿¼Ñе÷¼Á¡¿»¯Ñ§×¨Òµ 281·Ö£¬Ò»Ö¾Ô¸ËÄ´¨´óѧ£¬³ÏÐÄÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸Äϲý´óѧ£¬327·Ö£¬²ÄÁÏÓ뻯¹¤085600
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
²ÄÁÏѧ˶297ÒѹýËÄÁù¼¶Çóµ÷¼ÁÍÆ¼ö
ÒѾÓÐ5È˻ظ´
²ÄÁÏ080500µ÷¼ÁÇóÊÕÁô
ÒѾÓÐ6È˻ظ´
296Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸Î人Àí¹¤²ÄÁϹ¤³Ìר˶µ÷¼Á
ÒѾÓÐ7È˻ظ´
295¸´ÊÔµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

|
2Â¥2006-09-24 08:55:11













»Ø¸´´ËÂ¥